These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 12926646)

  • 1. New perspectives in the management of osteoarthritis. structure modification: facts or fantasy?
    Reginster JY; Bruyere O; Henrotin Y
    J Rheumatol Suppl; 2003 Aug; 67():14-20. PubMed ID: 12926646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence of nutriceutical effectiveness in the treatment of osteoarthritis.
    Reginster JY; Gillot V; Bruyere O; Henrotin Y
    Curr Rheumatol Rep; 2000 Dec; 2(6):472-7. PubMed ID: 11123100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Naturocetic (glucosamine and chondroitin sulfate) compounds as structure-modifying drugs in the treatment of osteoarthritis.
    Reginster JY; Bruyere O; Lecart MP; Henrotin Y
    Curr Opin Rheumatol; 2003 Sep; 15(5):651-5. PubMed ID: 12960496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effectiveness of drugs used in degenerative joint diseases (arthroses)].
    Sanfélix-Gimeno G; Reig-Mollá B; Sanfélix-Genovés J; Giner-Ruiz V
    Med Clin (Barc); 2008 Apr; 130(12):463-5. PubMed ID: 18405503
    [No Abstract]   [Full Text] [Related]  

  • 5. Nutraceuticals as therapeutic agents in osteoarthritis. The role of glucosamine, chondroitin sulfate, and collagen hydrolysate.
    Deal CL; Moskowitz RW
    Rheum Dis Clin North Am; 1999 May; 25(2):379-95. PubMed ID: 10356424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucosamine and chondroitin sulfate as therapeutic agents for knee and hip osteoarthritis.
    Bruyere O; Reginster JY
    Drugs Aging; 2007; 24(7):573-80. PubMed ID: 17658908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chondroitin Sulfate and Glucosamine as Disease Modifying Anti- Osteoarthritis Dru gs (DMOADs).
    Mantovani V; Maccari F; Volpi N
    Curr Med Chem; 2016; 23(11):1139-51. PubMed ID: 26980567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pharmacological treatment of osteoarthritis. Expectations and reality].
    Mulero Mendoza J
    Rev Clin Esp; 2005 Apr; 205(4):168-71. PubMed ID: 15860188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chondroitin for osteoarthritis.
    Singh JA; Noorbaloochi S; MacDonald R; Maxwell LJ
    Cochrane Database Syst Rev; 2015 Jan; 1(1):CD005614. PubMed ID: 25629804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Chondromodulation in 2003: dream or reality?].
    Reginster JY
    Rev Med Suisse Romande; 2004 Feb; 124(2):85-7. PubMed ID: 15095620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The efficacy of glucosamine and chondroitin sulfate in the treatment of osteoarthritis: are these saccharides drugs or nutraceuticals?
    Simánek V; Kren V; Ulrichová J; Gallo J
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2005 Jun; 149(1):51-6. PubMed ID: 16170388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of individuals with osteoarthritis in the United States and their use of prescription and over-the-counter supplements.
    Lane NE; Ivanova J; Emir B; Mobasheri A; Jensen MG
    Maturitas; 2021 Mar; 145():24-30. PubMed ID: 33541559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chondroitin sulphate: a focus on osteoarthritis.
    Bishnoi M; Jain A; Hurkat P; Jain SK
    Glycoconj J; 2016 Oct; 33(5):693-705. PubMed ID: 27194526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucosamine and chondroitin sulfate.
    Miller KL; Clegg DO
    Rheum Dis Clin North Am; 2011 Feb; 37(1):103-18. PubMed ID: 21220090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inappropriate claims from non-equivalent medications in osteoarthritis: a position paper endorsed by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO).
    Bruyère O; Cooper C; Al-Daghri NM; Dennison EM; Rizzoli R; Reginster JY
    Aging Clin Exp Res; 2018 Feb; 30(2):111-117. PubMed ID: 29177637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pharmacy clinics. How I treat...Osteoarthritis. 2nd part: new therapeutic perspectives].
    Reginster JY; Henrotin Y
    Rev Med Liege; 2001 Mar; 56(3):135-9. PubMed ID: 11338782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of various SYSADOA for the osteoarthritis treatment: an experimental study in rabbits.
    Permuy M; Guede D; López-Peña M; Muñoz F; Caeiro JR; González-Cantalapiedra A
    BMC Musculoskelet Disord; 2015 May; 16():120. PubMed ID: 25986068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucosamine/chondroitin/primorine combination therapy for osteoarthritis.
    Fox BA; Stephens MM
    Drugs Today (Barc); 2009 Jan; 45(1):21-31. PubMed ID: 19271029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of glucosamine sulfate and chondroitin sulfates in the treatment of degenerative joint disease.
    Kelly GS
    Altern Med Rev; 1998 Feb; 3(1):27-39. PubMed ID: 9600024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Literature Analysis Regarding the Combination of Substances: Glucosamine + Chondroitin in the Treatment of Osteoarthritis.
    Marczyński W; Tłustochowicz W; Tomaszewski W; Białecki J
    Ortop Traumatol Rehabil; 2022 Dec; 24(6):407-416. PubMed ID: 36734661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.